Oct 14, 2020 2:18 AM -
The country's chief public health officer says a delay in Johnson & Johnson's clinical trials for its COVID-19 vaccine may signal a delay in getting a vaccine to the general public.
She says everyone wants to see a vaccine ready as quickly as possible, but health and safety should never be compromised.
Johnson & Johnson paused a clinical trial of its COVID-19 vaccine after finding an unexplained illness, which is normal in large-scale studies.
These Phase 3 clinical trials involving human volunteers are supposed to wrap by November and December.